Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers.

Ticinesi A, Milani C, Guerra A, Allegri F, Lauretani F, Nouvenne A, Mancabelli L, Lugli GA, Turroni F, Duranti S, Mangifesta M, Viappiani A, Ferrario C, Dodi R, Dall'Asta M, Del Rio D, Ventura M, Meschi T.

Gut. 2018 Dec;67(12):2097-2106. doi: 10.1136/gutjnl-2017-315734. Epub 2018 Apr 28.

PMID:
29705728
2.

Role of gut microbiota against calcium oxalate.

Sadaf H, Raza SI, Hassan SW.

Microb Pathog. 2017 Aug;109:287-291. doi: 10.1016/j.micpath.2017.06.009. Epub 2017 Jun 15. Review.

PMID:
28624518
3.

Oxalobacter formigenes-associated host features and microbial community structures examined using the American Gut Project.

Liu M, Koh H, Kurtz ZD, Battaglia T, PeBenito A, Li H, Nazzal L, Blaser MJ.

Microbiome. 2017 Aug 25;5(1):108. doi: 10.1186/s40168-017-0316-0.

4.

Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.

Rendina D, De Filippo G, Zampa G, Muscariello R, Mossetti G, Strazzullo P.

Nephrol Dial Transplant. 2011 Jul;26(7):2256-63. doi: 10.1093/ndt/gfq664. Epub 2010 Nov 4.

PMID:
21051502
5.

The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease.

Knight J, Deora R, Assimos DG, Holmes RP.

Urolithiasis. 2013 Jun;41(3):187-96. doi: 10.1007/s00240-013-0566-7. Epub 2013 Apr 30. Review.

6.
7.

Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group.

Magwira CA, Kullin B, Lewandowski S, Rodgers A, Reid SJ, Abratt VR.

J Appl Microbiol. 2012 Aug;113(2):418-28. doi: 10.1111/j.1365-2672.2012.05346.x. Epub 2012 Jun 18.

8.

Effect of Dietary Oxalate on the Gut Microbiota of the Mammalian Herbivore Neotoma albigula.

Miller AW, Oakeson KF, Dale C, Dearing MD.

Appl Environ Microbiol. 2016 Apr 18;82(9):2669-2675. doi: 10.1128/AEM.00216-16. Print 2016 May.

9.

Comparative faecal microbiota of dogs with and without calcium oxalate stones.

Gnanandarajah JS, Johnson TJ, Kim HB, Abrahante JE, Lulich JP, Murtaugh MP.

J Appl Microbiol. 2012 Oct;113(4):745-56. doi: 10.1111/j.1365-2672.2012.05390.x. Epub 2012 Aug 2.

10.

The role of the microbiome in kidney stone formation.

Mehta M, Goldfarb DS, Nazzal L.

Int J Surg. 2016 Dec;36(Pt D):607-612. doi: 10.1016/j.ijsu.2016.11.024. Epub 2016 Nov 12. Review.

11.

Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.

Suryavanshi MV, Bhute SS, Jadhav SD, Bhatia MS, Gune RP, Shouche YS.

Sci Rep. 2016 Oct 6;6:34712. doi: 10.1038/srep34712.

12.

Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.

Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F; CLU Working Group.

Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Review. Erratum in: Arch Ital Urol Androl. 2016 Mar;88(1):76. Ferraro, Manuel [added].

13.

[Oxalobacter formigenes--characteristics and role in development of calcium oxalate urolithiasis].

Torzewska A.

Postepy Hig Med Dosw (Online). 2013 Nov 27;67:1144-53. Review. Polish.

14.

Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers.

Chai W, Liebman M, Kynast-Gales S, Massey L.

Am J Kidney Dis. 2004 Dec;44(6):1060-9.

PMID:
15558527
15.

16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones.

Tang R, Jiang Y, Tan A, Ye J, Xian X, Xie Y, Wang Q, Yao Z, Mo Z.

Urolithiasis. 2018 Nov;46(6):503-514. doi: 10.1007/s00240-018-1037-y. Epub 2018 Jan 20.

PMID:
29353409
16.

Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.

Wang Y, Gao X, Ghozlane A, Hu H, Li X, Xiao Y, Li D, Yu G, Zhang T.

J Crohns Colitis. 2018 Feb 28;12(3):337-346. doi: 10.1093/ecco-jcc/jjx153.

PMID:
29194468
17.

Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.

Otto BJ, Bozorgmehri S, Kuo J, Canales M, Bird VG, Canales B.

J Endourol. 2017 Dec;31(12):1335-1341. doi: 10.1089/end.2017.0352.

PMID:
29084490
18.

A metagenomic study of the gut microbiome in Behcet's disease.

Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, Du L, Cao Q, Tang J, Zhou C, Hou S, He Y, Xu Q, Xiong X, Kijlstra A, Qin N, Yang P.

Microbiome. 2018 Aug 4;6(1):135. doi: 10.1186/s40168-018-0520-6.

19.

The Impact of Anthelmintic Treatment on Human Gut Microbiota Based on Cross-Sectional and Pre- and Postdeworming Comparisons in Western Kenya.

Easton AV, QuiƱones M, Vujkovic-Cvijin I, Oliveira RG, Kepha S, Odiere MR, Anderson RM, Belkaid Y, Nutman TB.

MBio. 2019 Apr 23;10(2). pii: e00519-19. doi: 10.1128/mBio.00519-19.

20.

The association of the intestinal oxalate degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.

Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A.

BJU Int. 2019 May 30. doi: 10.1111/bju.14840. [Epub ahead of print]

PMID:
31145528

Supplemental Content

Support Center